Riskpilot← Back to searchSign inGet full accessTandläkare CLE AB
ABActiveOrg 5566649496Vikingagatan 23Dental practice care activities · NACE 8623Est. 20049 employees
Revenue 2024
SEK 7,3M
-5% vs 2023
EBITDA margin
-6.9%
+43% vs 2023
Equity ratio
40.6%
Financial strength
Net profit 2024
SEK 831K
+67% vs 2023
| Revenue | SEK 7,3M | -5% |
| EBITDA | SEK -507K | +43% |
| Net profit | SEK 831K | +67% |
| Total assets | SEK 2,4M | +68% |
| Equity | SEK 979K | +31% |
| Employees | 9 | — |
Legal name
Tandläkare CLE AB
Org number
5566649496
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
13 augusti 2004
Share capital
SEK 100 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandläkarpraktik och därmed förenlig verksamhet.
Address
Vikingagatan 23
Phone
+46406116890
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 424 | 7 909 | 8 536 | 7 723 | 7 315 |
| Staff expenses | — | — | — | — | −4 599 |
| EBITDA | 461 | 263 | 466 | −891 | −507 |
| Depreciation & amort. | −143 | −149 | −78 | −109 | −49 |
| EBIT | 318 | 114 | 388 | −1 000 | −556 |
| Net financials | 240 | 244 | 497 | 1 195 | 586 |
| Profit before tax | 665 | 327 | 865 | 498 | 831 |
| Tax | −92 | −21 | −78 | −0 | — |
| Net profit | 573 | 306 | 787 | 498 | 831 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 093 | 2 483 | 2 495 | 1 433 | 2 412 |
| Equity | 1 058 | 1 164 | 1 450 | 749 | 979 |
| Long-term debt | 45 | 0 | 0 | 74 | 41 |
| Short-term debt | 739 | 1 036 | 742 | 610 | 1 391 |
| Total debt | 784 | 1 036 | 742 | 684 | 1 433 |
EBITDA margin
-6.9%
This company
15.8%
Market median
-144% vs market
20202024
Equity ratio
40.6%
This company
38.2%
Market median
+6% vs market
20202024
Return on equity
84.8%
This company
18.4%
Market median
+361% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
3.03×
This company
1.12×
Market median
+171% vs market
20202024
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH | Audit | 2023 |
| Former (1) | ||
GI | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tandläkare CLE AB 
Viking Medtech ABBoard members of Tandläkare CLE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerd Ingrid Sollerhed Fahlén | Audit | 0 companies |
| Johan Håkan Malmqvist | Audit | 0 companies |
| Martin Niklas Erixon | Deputy Board Member | 0 companies |
| Lisbeth Caroline Erixon | Board of Directors | 0 companies |